Clinical trial
A Randomized, Double-blind, and Placebo-controlled Study on the Treatments of Irritable Bowel Syndrome
NCT02330029 is registered in ClinicalTrials.gov with Macrohard Institute of Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, and Placebo-controlled Study on the Treatments of Irritable Bowel Syndrome
- Lead sponsor
- Macrohard Institute of Health
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 31, 2012
- Completion date
- May 31, 2017
- Enrollment
- 800 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.